Study on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma
- Substances:PembrolizumabResiquimod Sulfate
Austria- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Pembrolizumab
Rare diseases
Investigational molecules
Locations
AustriaStudy of [18F]AlF-NOTA-Octreotide for Carotid Artery Disease in Patients with Recent Stroke or TIA
BelgiumStudy of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response
BelgiumComparison of Once Versus Twice Daily Prednisolone Administration on Blood Glucose Control in Patients with ANCA-Associated Vasculitis
AustriaStudy on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)
BelgiumStudy of nivolumab treatment for patients with nasopharyngeal cancer who did not respond to or worsened after platinum chemotherapy
PolandStudy on Pressurized Intraperitoneal Aerosol Chemotherapy with Fluorouracil for Patients with Gastric Cancer with Peritoneal Metastases
ItalyStudy on Steroid Withdrawal in Systemic Lupus Erythematosus Patients Using Prednisone
ItalyStudy on Stopping Prednisone for Patients with Inflammatory or Autoimmune Disorders
GermanyStudy on the Effectiveness of Dexamethasone in Preventing Prenatal Virilization in Female Patients with Congenital Adrenal Hyperplasia
GermanyStudy on Methotrexate and Prednisone for Treating Lung Sarcoidosis in Patients
The NetherlandsStudy on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.